The board of directors of Lansen Pharmaceutical Holdings Limited announced that due to other work commitments, Ms. Yip Pui Ling, Rebecca and Ms. Tao Fang Fang have resigned as Non-executive Directors of the Company of the Company with effect from March 30, 2016. Upon her resignation, Ms. Yip will cease to be a member of the Audit Committee of the Company and one of the authorized representatives of the Company (for the purpose of Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. The company announced that Ms. Liu Xuezi has been appointed as a Non-executive Director with effect from March 30, 2016.

Ms. LIU Xuezi, age 39, is a Non-executive Director of the Company. Ms. Liu joined Cathay International Holdings Limited in 2002 and has been working in the corporate development department and asset management department. She is currently the vice president and co-head of asset management of Cathay and she is the director of various subsidiaries of the Group.

Ms. Liu has entered into a letter of appointment with the Company for a term of three years commencing on March 30, 2016. The Board announces that Mr. Hou Song will be appointed as the Executive Director and authorized representative of the Company and a member of the Executive Committee with effect from 30 March 2016. Mr. Hou Song, age 40, is the Executive Director and the chief financial officer of the Company.

Mr. Hou joined the Group in September 2015.